Skip to main navigation
  • Investors
Alnylam

Michael W. Bonney

Chair

Partner, Third Rock Ventures; former Chief Executive Officer and Director of Cubist Pharmaceuticals; Director of Celgene Corporation and Global Blood Therapeutics, Inc.; and trustee of Tekla Healthcare Investors and Tekla Life Sciences Investors, both publicly traded investment funds.

Chairman of the Board
  • Member of the Audit Committee
  • Member of the Nominating and Corporate Governance Committee

Recent Press Releases

View all releases  RSS

  • Mar 30,2026
    Summary ToggleNew Data Presented at ACC.26 Further Support Benefits of Vutrisiran in ATTR-CM and Potential of Zilebesiran for Hypertension Management
  • Mar 24,2026
    Summary ToggleAlnylam Advances Future of ATTR-CM Care Through Strategic Collaboration with Viz.ai and Support for the American Heart Association
  • Mar 10,2026
    Summary ToggleAlnylam to Webcast TTR Investor Webinar
View all releases

: (Common):

Price:
Change (%):
Volume:
Data as of
Copyright Refinitiv. Minimum 15 minutes delay
Learn More
  • X
  • linkedin
  • youtube

Copyright © 2026 Alnylam Pharmaceuticals, Inc.   ---   All Rights Reserved   ---   Media Kit   |   Legal Notice   |   Privacy Policy   |   Site Map